{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:28Z","timestamp":1786988188834,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ekir.2023.01.015","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T15:45:31Z","timestamp":1674143131000},"page":"818-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-4864","authenticated-orcid":false,"given":"Nikoline B.","family":"Rinde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-7492","authenticated-orcid":false,"given":"Inger Therese","family":"Enoksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toralf","family":"Melsom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Martin","family":"Fuskev\u00e5g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Odvar","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Viljar","family":"Norvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2023.01.015_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.015_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2023.01.015_bib3","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1681\/ASN.2017040421","article-title":"Structural and functional changes in human kidneys with healthy aging","volume":"28","author":"Hommos","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","article-title":"Structural and functional changes with the aging kidney","volume":"23","author":"Denic","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.015_bib5","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2019010008","article-title":"Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data","volume":"30","author":"Grams","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ki.2008.200","article-title":"Gender differences in predictors of the decline of renal function in the general population","volume":"74","author":"Halbesma","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.015_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.015_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.2000.3169","article-title":"Regulation of nitric oxide production by arginine metabolic enzymes","volume":"275","author":"Mori","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ekir.2023.01.015_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heart.85.3.342","article-title":"Endothelial function and nitric oxide: clinical relevance","volume":"85","author":"Vallance","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ekir.2023.01.015_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1567-5688(03)00030-8","article-title":"ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease","volume":"4","author":"B\u00f6ger","year":"2003","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.ekir.2023.01.015_bib11","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: A new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-B\u00f6ger","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib12","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.3390\/ijms130911288","article-title":"Asymmetric dimethylarginine, endothelial dysfunction and renal disease","volume":"13","author":"Ald\u00e1miz-Echevarr\u00eda","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2023.01.015_bib13","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.015_bib14","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.015_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpneph0143","article-title":"Arginine, arginine analogs and nitric oxide production in chronic kidney disease","volume":"2","author":"Baylis","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib17","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1681\/ASN.2005020179","article-title":"Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study","volume":"16","author":"Fliser","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1681\/ASN.2012101006","article-title":"A\u00a0combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biomedicines8070222","article-title":"Amino acid metabolites associated with chronic kidney disease: an eight-year follow-up Korean epidemiology study","volume":"8","author":"Lee","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.ekir.2023.01.015_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000371557","article-title":"Estimated GFR is biased by non-traditional cardiovascular risk factors","volume":"41","author":"Melsom","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2215\/CJN.09280916","article-title":"Association of TNF Receptor 2 and CRP with GFR decline in the general nondiabetic population","volume":"12","author":"Schei","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.ekir.2023.01.015_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Tromso Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ekir.2023.01.015_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.kint.2016.03.021","article-title":"Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population","volume":"90","author":"Eriksen","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.015_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ki.2010.321","article-title":"Cystatin C is not a better estimator of GFR than plasma creatinine in the general population","volume":"78","author":"Eriksen","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.015_bib26","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1681\/ASN.2022030323","article-title":"Sex differences in age-related loss of kidney function","volume":"33","author":"Melsom","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/HJH.0b013e32834f973a","article-title":"Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population","volume":"30","author":"Mathisen","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ekir.2023.01.015_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2008.02.027","article-title":"Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study","volume":"201","author":"Solbu","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2023.01.015_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ckj\/sfw071","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2023.01.015_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1475-097X.1983.tb00712.x","article-title":"A\u00a0method for the calculation of renal clearance based on a single plasma sample","volume":"3","author":"Jacobsson","year":"1983","journal-title":"Clin Physiol"},{"key":"10.1016\/j.ekir.2023.01.015_bib31","first-page":"48","article-title":"Iohexol clearance for the determination of glomerular filtration rate: 15 years\u2019 experience in clinical practice","volume":"13","author":"Nilsson-Ehle","year":"2001","journal-title":"EJIFCC"},{"issue":"6_2","key":"10.1016\/j.ekir.2023.01.015_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known","volume":"XVII","author":"Du Bois","year":"1916","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ekir.2023.01.015_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/j.ajkd.2015.10.025","article-title":"Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study","volume":"67","author":"Melsom","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.015_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/gfac241","article-title":"Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa","volume":"38","author":"Delanaye","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.01.015_bib35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/HYPERTENSIONAHA.117.09020","article-title":"High ambulatory arterial stiffness index is an independent risk factor for rapid age-related glomerular filtration rate decline in the general middle-aged population","volume":"69","author":"Eriksen","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2023.01.015_bib36","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/ndt\/gfaa208","article-title":"Urinary excretion of epidermal growth factor and rapid loss of kidney function","volume":"36","author":"Norvik","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.01.015_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2369-15-45","article-title":"Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art","volume":"15","author":"Boucquemont","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.015_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-020-01762-3","article-title":"Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging","volume":"17","author":"Yamaguchi","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.ekir.2023.01.015_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","article-title":"Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases","volume":"336","author":"Fleck","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2023.01.015_bib41","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2023.01.015_bib42","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function\u2014a meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2023.01.015_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00726-005-0268-8","article-title":"Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease-possible candidates for paradoxical epidemiology?","volume":"30","author":"Busch","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.ekir.2023.01.015_bib44","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"Malyszko","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2023.01.015_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251308","article-title":"Biomarkers representing key aging-related biological pathways are associated with subclinical atherosclerosis and all-cause mortality: the Framingham Study","volume":"16","author":"Castro-Diehl","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2023.01.015_bib46","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1681\/ASN.2009020171","article-title":"Measured GFR as a confirmatory test for estimated GFR","volume":"20","author":"Stevens","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1681\/ASN.2010050479","article-title":"Estimated GFR associates with cardiovascular risk factors independently of measured GFR","volume":"22","author":"Mathisen","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.015_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.atherosclerosis.2011.04.041","article-title":"Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography","volume":"218","author":"Sourij","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2023.01.015_bib49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1046\/j.1523-1755.2000.00281.x","article-title":"Total nitric oxide production is low in patients with chronic renal disease","volume":"58","author":"Schmidt","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.015_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1253\/circj.CJ-12-0602","article-title":"High citrulline-to-arginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease","volume":"77","author":"Lin","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.ekir.2023.01.015_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ypmed.2011.07.017","article-title":"Non-response bias in a web-based health behaviour survey of New Zealand tertiary students","volume":"53","author":"Kypri","year":"2011","journal-title":"Prev Med"}],"updated-by":[{"DOI":"10.1016\/j.ekir.2024.05.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T18:09:19Z","timestamp":1719425359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2468024923000165"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.015","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}